Ron Lim

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial

Didier Jutras‐Aswad, Bernard Le Foll, Keith Ahamad et al. · American Journal of Psychiatry · 2022 · 55 citations

Medicine, Pharmacology, Pharmacotherapy +12

The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale

M. Eugenia Socías, Keith Ahamad, Bernard Le Foll et al. · Contemporary Clinical Trials · 2018 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +13

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: secondary analysis of a Canadian treatment trial

M. Eugenia Socías, Evan Wood, Bernard Le Foll et al. · Addiction · 2022 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the OPTIMA study

Hamzah Bakouni, Christina McAnulty, Ovidiu Tatar et al. · American Journal on Addictions · 2023 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial

Christina McAnulty, Gabriel Bastien, M. Eugenia Socías et al. · Drug and Alcohol Dependence · 2022 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15